The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
Gamestop Corp
GME · the NYSE · USD · Market cap $11.5B · 4,000 employees
GameStop Corp., a specialty retailer, provides games, collectibles, and entertainment products through its stores and e-commerce platforms in United States, Australia and Europe.
FAIL · Does not pass the screenAt the last full screen
2026-09-17
Screened 2026-09-17 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Gamestop Corp holds its Accumulation at $22.77. The statistical read favours the buyers, held for 225 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 225 days |
| Price at the screen | $22.77 |
| Valuation | 14.98 trailing · 12.24 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.71 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 41.99% | Below 33% | Interest-bearing debt is 42.0% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 26.08% | Below 33% | Cash held in interest-bearing accounts and securities is 26.1% of assets, under the one-third limit. | Pass |
| Receivables | 61.12% | Below 49% | Money owed to the company is 61.1% of assets, above the 49% limit. | Fail |
| Revenue purity | 7.48% | Below 5% | 7.5% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-17 screen. The gold marker is the market price at the same screen. A 47.4% margin of safety to the base estimate.
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsRetail Store Chain Clings To Fading Model
Step inside a GameStop and you still see rows of game cases and consoles, yet most players now download titles in seconds without ever visiting a shop. The numbers show 14 percent revenue growth, a 20 percent profit margin and 14 percent ROE, yet these sit alongside a weak moat and a price above our fair value estimate.
We pass because the forward multiple of 16 times offers no margin of safety and the business lacks any lasting edge against digital platforms and bigger online rivals. Ethical screens clear, but that alone does not create value when competitive position stays thin.
Specialty retail stays cyclical, so earnings can drop fast if console cycles slow or consumer spending tightens. A low multiple on peak margins often signals a trap rather than a bargain here. Analysis, not advice.
| Forward P/E | 12.2xreasonably valued |
| Trailing P/E | 15.0xreasonably valued |
| EPS, trailing | 1.52 |
| EPS, forward | 1.86 |
| Revenue growth | -18.7%revenue is shrinking |
| Profit margin | 25.2%healthy profit margins |
| Return on equity | 15.8%a solid return on shareholder capital |
| FCF yield | 0.74% |
| Debt to equity | 0.71moderate, manageable leverage |
| Current ratio | 8.72comfortably covers its short-term bills |
| Beta | 1.71much more volatile than the market |
| Short interest, float | 0.14% |
| 52-week range | 17.79 - 28.10 |
| Moat | WEAK |
| Market cap | $11.5B |
| Employees | 4,000 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGME trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $23.17 | -2.6% | · | $974 | -2.6% |
| 2 months | $23.22 | -2.8% | · | $972 | -2.8% |
| 3 months | $24.43 | -7.6% | · | $924 | -7.6% |
| 6 months | $21.86 | +3.3% | · | $1,033 | +3.3% |
| 1 year | $30.15 | -25.1% | · | $749 | -25.1% |
| 2 years | $24.83 | -9.1% | · | $909 | -9.1% |
| 3 years | $22.68 | -0.5% | · | $995 | -0.5% |
| 5 years | $58.33 | -61.3% | · | $387 | -61.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GME does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.